MoneyWorks4Me

Ami Organics informs about statement of deviation or variation

29 Jan 2025 Evaluate
Pursuant to Regulation 32(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulation, 2015 Ami Organics has enclosed the statement of deviation(s) or variation(s) in utilisation of Qualified Institutions Placement (QIP) Issue proceeds, for quarter ended December 31, 2024 pertaining to the Qualified Institutions Placement of equity shares of the Company in the prescribed format. We confirm that, as at December 31, 2024 there has not been any deviation(s) or variation(s) in the utilization of net proceeds of Qualified Institutions Placement of equity shares allotted on June 21, 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..